RFA
LOXO

Reilly Financial Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Reilly Financial Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-400
Closed -$68K – 1067
2018
Q3 		$68K Buy
+400
New +$67.2K 0.01% 307

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Reilly Financial Advisors's LOXO Position: Q4 2018 in Review

Reilly Financial Advisors sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 400 shares — an estimated $68K sold.

Reilly Financial Advisors first reported a position in LOXO in Q3 2018 and held it in 1 quarter. The position peaked at $68K in Q3 2018. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Reilly Financial Advisors reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Reilly Financial Advisors sold 400 Loxo Oncology, Inc shares in Q4 2018, an estimated $68K.
  • Reilly Financial Advisors first reported a position in Loxo Oncology, Inc in Q3 2018 and held it in 1 quarter.
  • Reilly Financial Advisors's Loxo Oncology, Inc position peaked at $68K in Q3 2018.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Reilly Financial Advisors's 13F filing for Q4 2018, filed 29 Jan 2019.